LXEO Lexeo Therapeutics PE ratio, current and historical analysis

The current PE ratio of LXEO can't be determined, as the TTM EPS of -$3.09 is negative. The last PE ratio of Lexeo Therapeutics, recorded in September 2024, was 0.52.

LXEO PE ratio history

How has LXEO's PE ratio performed in the past

Today

N/A

Average

N/A

Median

N/A

Minimum

N/A

Maximum

N/A

Lexeo Therapeutics PE ratio by year

Year	PE ratio	PE change	Price	EPS
2024	N/A	N/A	$6.58	-$3.09
2023	N/A	N/A	$13.42	-$12.4
2022	N/A	N/A	N/A	-$36.36
2021	N/A	N/A	N/A	-$32.6

Lexeo Therapeutics PE ratio by quarter (TTM)

Year	PE ratio	PE change	Price	EPS
Dec 2024	N/A	N/A	$6.58	-$3.09
Sep 2024	0.52	-80.3%	$9.04	$17.54
Jun 2024	2.64	N/A	$16.04	$6.07
Mar 2024	N/A	N/A	$15.68	-$1.59
Dec 2023	N/A	N/A	$13.42	-$12.4
Sep 2023	N/A	N/A	N/A	-$41.1
Jun 2023	N/A	N/A	N/A	-$39.12
Mar 2023	N/A	N/A	N/A	-$40.05
Dec 2022	N/A	N/A	N/A	-$36.36
Sep 2022	N/A	N/A	N/A	N/A
Jun 2022	N/A	N/A	N/A	N/A
Dec 2021	N/A	N/A	N/A	-$32.6

LXEO average PE ratio chart

What is the average PE ratio of LXEO for the past years

3-year avg

N/A

5-year avg

N/A

10-year avg

N/A

15-year avg

N/A

LXEO PE vs peers

What is LXEO's PE ratio compared to its peers

Stock name	PE ratio	Market cap
NTLA Intellia Therapeutics Inc	N/A	$750.5M
BLUE bluebird bio Inc	N/A	$37.59M
CRSP CRISPR Therapeutics AG	N/A	$2.84B
EDIT Editas Medicine Inc	N/A	$110.36M
QURE uniQure NV	N/A	$620.8M
RGNX REGENXBIO Inc	N/A	$396.68M
SGMO Sangamo Therapeutics Inc	N/A	$137.52M
ADVM Adverum Biotechnologies Inc	N/A	$67.48M
BEAM Beam Therapeutics Inc	N/A	$1.34B
VERV Verve Therapeutics Inc	N/A	$387.15M
LXEO Lexeo Therapeutics Inc.	N/A	$107.89M

Frequently asked questions

What is Lexeo Therapeutics's PE ratio?

The current price to earnings ratio of LXEO can't be calculated, as its EPS of -$3.09 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.